Surgimab
Industry · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoin Colorectal Neoplasms | Phase 3 | 2019-06-17 |
| Completed | Phase I of SGM-101 in Patients With Cancer of the Colon, Rectum or Pancreas Colon Cancer, Rectum Cancer, Pancreas Cancer | Phase 1 / Phase 2 | 2016-01-01 |